CymitQuimica logo

RTI-177

CAS:

Ref. 3D-VGA93995

1mg
Discontinued
5mg
Discontinued
10mg
Discontinued
25mg
Discontinued
50mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

RTI-177
Biosynth

Product Information

Name:RTI-177
Controlled Product
Brand:Biosynth
Description:RTI-177 is a human analog of ceftiofur, which acts as a potent inhibitor of kinases. It has shown potential as an anticancer agent in Chinese hamster ovary cells by inducing apoptosis and inhibiting tumor growth. RTI-177 is also effective against cancer cell lines and has been shown to inhibit the activity of various kinases involved in cell proliferation and survival. This inhibitor has been found in urine samples from cancer patients, indicating its potential as a biomarker for early detection of cancer. RTI-177 is a promising candidate for the development of new protein kinase inhibitors with therapeutic potential for cancer treatment.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:240.21 g/mol
Formula:C10H8F2N4O
Purity:Min. 95%

Inquiry about discontinued product: RTI-177

◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.